Business Context and Reporting Period
This Form 8-K was filed by Trovagene, Inc. (not Cardiff Oncology, Inc.) on November 28, 2017. The registrant is a Delaware corporation headquartered in San Diego, California. The filing serves as a Regulation FD disclosure regarding the company's intent to conduct meetings with third parties using a corporate slide presentation.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report is a disclosure of presentation materials rather than a financial statement.
Material Changes
No material financial changes versus a prior comparable period are reported in this document. The filing solely announces the distribution of corporate presentation materials to third parties.
Guidance, Outlook, and Risks
Management Commentary: The company intends to present its corporate slide deck to third parties. The presentation is attached as Exhibit 99.1.
Legal Status of Information: The information in Item 7.01 and Exhibit 99.1 is furnished and shall not be deemed "filed" under Section 18 of the Exchange Act. It is not subject to the liabilities of that section nor incorporated by reference in other filings unless expressly stated.
Investor Verification Checklist
- Verify the correct registrant name is Trovagene, Inc., not Cardiff Oncology, Inc.
- Review Exhibit 99.1 (Corporate Presentation) for specific business updates, as the 8-K text itself contains no operational data.
- Note that the presentation materials are not legally "filed" for liability purposes under Section 18 of the Exchange Act.
- Confirm that no financial metrics are disclosed in this specific filing.